BAL detected pathogens in 61% of cases and led to treatment changes in nearly 9 out of 10 immunocompromised children with acute respiratory illness, according to a new 5-year study.
A large matched-cohort study found that COVID-19 vaccination was linked to a reduced risk of developing fibromyalgia among survivors, particularly in men and those with depression or anxiety.
A new study found colon cancer patients with cannabis use disorder were more than 10 times more likely to die within five years, even after adjusting for age and disease severity.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
A new single-dose chikungunya vaccine produced strong immune responses in nearly all adolescents and adults in a large clinical trial, with mild and short-lived side effects.
April’s FDA approvals feature first-in-class therapies, targeted biologics, expanded indications, and innovative delivery systems across allergy, endocrinology, rheumatology, oncology, infectious diseases, and more.
A digital asthma symptom monitoring app modestly improved patient-reported quality of life, with greater benefits seen in younger adults and those with low self-management skills.